Published in Dig Dis Sci on March 01, 1989
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int (2011) 1.43
Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond. Br J Clin Pharmacol (2004) 1.03
Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf (2009) 0.94
Current perspectives in NSAID-induced gastropathy. Mediators Inflamm (2013) 0.91
Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs. Oman Med J (2011) 0.86
Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration. Gut (1997) 0.86
Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials. Dig Dis Sci (2001) 0.83
Association between adherence to evidence-based guidelines for the prescription of non-steroidal anti-inflammatory drugs and the incidence of gastric mucosal lesions in Japanese patients. J Gastroenterol (2010) 0.80
Gastroprotective effect of ranitidine bismuth citrate is associated with increased mucus bismuth concentration in rats. Gut (1996) 0.76
Improving the gastrointestinal safety of NSAIDs: the development of misoprostol--from hypothesis to clinical practice. Dig Dis Sci (1998) 0.76
Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis. Ann Rheum Dis (1993) 0.76
Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans. Gut (1997) 0.76
Management of NSAID-related gastrointestinal mucosal injury. Inflammopharmacology (1999) 0.76
The role of prostaglandins in gastric mucosal protection. Trans Am Clin Climatol Assoc (1996) 0.76
NSAIDs and peptic ulcers. BMJ (1990) 0.75
The influence of food, beverages and NSAIDs on gastric acid secretion and mucosal integrity. Yale J Biol Med (1997) 0.75
Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology (2007) 8.08
The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60
Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Environmental investigations of Vibrio parahaemolyticus in oysters after outbreaks in Washington, Texas, and New York (1997 and 1998). Appl Environ Microbiol (2000) 2.50
The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol (1997) 2.47
Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci (1998) 2.43
Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell (1993) 2.40
Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci U S A (1987) 2.36
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study. Dig Dis Sci (1979) 2.29
Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol (1993) 2.23
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology (1977) 2.19
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology (1997) 2.15
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol (1988) 2.12
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09
Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol (1987) 2.05
Control of axonal caliber by neurofilament transport. J Cell Biol (1984) 2.03
Slow axonal transport of neurofilament proteins: impairment of beta,beta'-iminodipropionitrile administration. Science (1978) 2.00
Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J Neurosci (2006) 1.97
Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95
Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology (1995) 1.95
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci (1995) 1.88
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum (1998) 1.79
Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol (1989) 1.79
Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med (1980) 1.72
Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J Neurosci (2001) 1.66
Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med (1984) 1.63
Schwann cell phenotype is regulated by axon modality and central-peripheral location, and persists in vitro. Exp Neurol (2013) 1.62
Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol (1988) 1.60
Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology (1993) 1.59
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59
Changes in neurofilament transport coincide temporally with alterations in the caliber of axons in regenerating motor fibers. J Cell Biol (1985) 1.55
Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J Neurocytol (1993) 1.54
Pathogenesis of Borna disease in rats: evidence that intra-axonal spread is the major route for virus dissemination and the determinant for disease incubation. J Virol (1987) 1.53
Regional modulation of neurofilament organization by myelination in normal axons. J Neurosci (1994) 1.49
Sensory nerve pathology in multifocal motor neuropathy. Ann Neurol (1996) 1.46
Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology (2000) 1.45
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology (2006) 1.45
HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst (2001) 1.45
Physiologic-pathologic correlation in Guillain-Barré syndrome in children. Neurology (2000) 1.43
The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology (2006) 1.42
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40
Subunit composition of neurofilaments specifies axonal diameter. J Cell Biol (1996) 1.39
Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol (1998) 1.39
Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing. Gastroenterology (1989) 1.39
Co-localization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibres. J Neurocytol (1989) 1.37
Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp Neurol (1994) 1.36
High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J Neurochem (2000) 1.34
Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol (1988) 1.34
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain (2002) 1.34
Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol (1987) 1.33
The axonal pathology in chronic IDPN intoxication. J Neuropathol Exp Neurol (1980) 1.30
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol (1999) 1.28
Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology (1997) 1.27
Natural history of benign esophageal stricture treated by dilatation. Gastroenterology (1983) 1.27
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology (1977) 1.26
Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. J Neuroimmunol (2008) 1.26
Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons. J Cell Biol (1995) 1.25
Effect of muscle disuse on acetylcholine receptors. Nature (1976) 1.25
Corrosive injury to the stomach: the natural history and role of fiberoptic endoscopy. Am J Surg (1979) 1.24
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol (1990) 1.21
Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol (1997) 1.20
A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J Gastroenterol (1981) 1.20
Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.19
Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet (1998) 1.19
Lymphomatous leptomeningitis. Am J Med (1971) 1.18
Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther (2001) 1.17
Effects of aging on nerve sprouting and regeneration. Exp Neurol (1980) 1.17
Is the six-weeks postnatal examination necessary? Practitioner (1985) 1.17
Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy. J Neurol Sci (1999) 1.16
Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol (1976) 1.15
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology (1998) 1.14
Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol (1988) 1.13
Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology (2001) 1.12
Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology (2004) 1.12
Slowing of neurofilament transport and the radial growth of developing nerve fibers. J Neurosci (1985) 1.12
Astrocytes and Schwann cells are virus-host cells in the nervous system of rats with Borna disease. J Neuropathol Exp Neurol (1989) 1.12
Toxic neuropathy in patients with pre-existing neuropathy. Neurology (2003) 1.11
The evolution of the pathway and its role in improving patient care. Qual Saf Health Care (2010) 1.11
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Microtubule-neurofilament segregation produced by beta, beta'-iminodipropionitrile: evidence for the association of fast axonal transport with microtubules. J Neurosci (1983) 1.10
Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment. J Virol (1995) 1.09
Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy. J Neurol Neurosurg Psychiatry (1998) 1.07
Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther (1998) 1.07
Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve (1994) 1.07
Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.07
Neutron reflectivity studies of critical adsorption: the correspondence between a critical adsorption profile and specular neutron reflection. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 1.07
Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain (1999) 1.06
Differences in elbow flexion torque measured concentrically, eccentrically, and isometrically. Phys Ther (1987) 1.06
Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Ann Neurol (1991) 1.06
Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies. Brain (2004) 1.06
Growth and survival of Vibrio parahaemolyticus in postharvest American oysters. J Food Prot (2002) 1.06
The distribution of ganglioside-like moieties in peripheral nerves. Brain (1999) 1.05
Developing culturally sensitive HIV/AIDS and substance abuse prevention curricula for Native American youth. J Sch Health (1996) 1.05
The pathogenesis of reactive axonal swellings: role of axonal transport. J Neuropathol Exp Neurol (1977) 1.05